The report provides insight into the clinical development environment,
sponsor and service provider activities, and population health status
for Russia. With this report, sponsors and service providers can make
informed strategic development decisions by understanding the benefits
and drawbacks to conducting trials in Russia.

How You Can Use This Report:

Understand how sponsors and CROs view Rusia as a site for clinical
trials and where the country fits within their clinical development
strategy

Uncover logistical details for conducting Russian trials

Illustrate the benefits and drawbacks of conducting trials in Russia

Target (News - Alert) specific indications by learning how Russia compares to other
countries on a variety health statistics

Set realistic expectations for trial operations and timing by
reviewing historic, country specific trial metrics

What You Will Learn in This Report:

On-the-ground insights from several industry KOLs from top pharma
companies and country heads from a multinational CRO

How its economy and national policies make Russia an attractive
country for clinical trial activity, and why regulatory uncertainty
and process challenges remain

Health statistics for Russia, including life expectancy, cancer and
AIDS incidence rates, alcohol and tobacco consumption, and more

Capabilities of domestic service providers and contact details for
domestic pharmaceutical companies

Regulatory environment/ considerations and how they compare to EU
standards